News
The anti-obesity medication semaglutide may help to prevent heart attacks and other major adverse cardiac events among overweight people who have cardiovascular disease, whether or not they also have heart failure, according to a new UCL-led study. The results follow previous research* from the same international team finding that weekly injections of semaglutide were linked [...]
Researchers investigating how changes in neural pathways affect recovery from spinal cord injury hope their findings may lead to major advancements in neurorehab. Stroke and spinal cord injuries can severely impair motor functions, and understanding how to promote recovery is a critical challenge. While damaged neurons in the brain and spinal cord have limited ability [...]
New research has highlighted how understanding the blood-brain barrier may allow for the development of targeted treatments of neurological diseases. Scientists at Southwest Research Institute have developed a new screening method to identify drug formulations that can penetrate the blood-brain barrier (BBB), to facilitate treatment of brain diseases and conditions. “The BBB protects the brain [...]
The second-annual NR Times Awards will celebrate some of the most exciting examples of innovation in the field. Sponsored by Slater and Gordon, the Neuro Rehab Innovation of the Year award promises to be highly competitive, with a number of exciting entries already in our submissions inbox. As we count down to the awards, we [...]
Researchers in Germany have implicated a new gene in the progression of Huntington’s disease, which may contribute to brain abnormalities much earlier than previously thought. For the first time, researchers have implicated the gene CHCHD2 in Huntington’s Disease (HD) – an incurable genetic neurodegenerative disorder – and identified the gene as a potentially new therapeutic [...]
A charity which supports disabled young people and their families across Sussex has partnered with law firm Slater and Gordon to help deliver its vital services. Amaze works across Brighton & Hove and East Sussex to give information, advice and support to families who have children with special educational needs and disabilities. The charity offers [...]
The UK Medicines and Healthcare products Regulatory Agency (MHRA) has approved a product licence for the medicine lecanemab (Leqembi) for use in the early stages of Alzheimer’s disease, following a thorough review of the benefits and risks. Lecanemab is the first treatment for Alzheimer’s disease licensed for use in Great Britain that shows some evidence [...]
A groundbreaking study has unveiled significant findings that could enhance brain-computer interface (BCI) technologies, marking a crucial step towards more intuitive neuroprosthetic control and advanced rehabilitation therapies. The study employed high-density electroencephalogram (EEG) recordings to delve into the neural dynamics of motor and tactile imagery. Brain-computer interfaces, devices that translate brain activity into commands for [...]
Nominate or enter our celebration of the brightest lights in neuro-rehab for free below.
The risk of early heart failure after heart transplantation is lower if the donor heart is stored in a so-called heart-in-a-box instead of in the usual cooler with ice, according to new research from the University of Gothenburg. The established way of storing donated hearts before transplantation is to keep them at four degrees in [...]
